Stay updated on Fremanezumab Subq for Migraine Preven Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.

Latest updates to the Fremanezumab Subq for Migraine Preven Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a minor update to the page's software revision.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were added, with the Intervention/Treatment label updated and the revision tag raised to v3.6.0.SummaryDifference0.2%

- Check22 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor maintenance update to the page version rather than substantive content changes.SummaryDifference0.0%

- Check43 days agoChange DetectedThe revision was updated from v3.5.3 to v3.5.4, signaling a new release of the page's metadata. This appears to be a maintenance update rather than a substantive change to the study content.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page’s footer revision/version number was updated from **v3.5.2** to **v3.5.3**, indicating a minor site release/version change without changing any study information.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded revision: v3.5.2 and removed revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Fremanezumab Subq for Migraine Preven Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.